Charles Kane
Known title: DirectorCIK: 0001203561
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Barlow Lowers Alkami Target to $15; AI and Fraud News. Barclays cut its price target for Alkami to $15 while keeping an Equal-Weight rating. The company also highlighted how its platform helped customers prevent over $263 million in fraud and discussed new AI governance tools for banks. These updates show Alkami is focusing on security and AI adoption, though the lower analyst target reflects cautious expectations.
Transaction History
| SYM | ▼ Sell | Other | 2,000 | — | 10/1/2026 | View on chart |
| SYM | ▼ Sell | Other | 2,000 | — | 10/1/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 1,100 | $47K | 10/1/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 900 | $39K | 10/1/2026 | View on chart |
| SYM | ▼ Sell | Other | 2,000 | — | 9/1/2026 | View on chart |
| SYM | ▼ Sell | Other | 2,000 | — | 9/1/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 2,000 | $78K | 9/1/2026 | View on chart |
| SYM | ▼ Sell | Other | 2,000 | — | 8/3/2026 | View on chart |
| SYM | ▼ Sell | Other | 2,000 | — | 8/3/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 2,000 | $86K | 8/3/2026 | View on chart |
| SYM | ▼ Sell | Other | 2,000 | — | 7/1/2026 | View on chart |
| SYM | ▼ Sell | Other | 2,000 | — | 7/1/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 2,000 | $90K | 7/1/2026 | View on chart |
| SYM | ▼ Sell | Other | 2,000 | — | 6/1/2026 | View on chart |
| SYM | ▼ Sell | Other | 2,000 | — | 6/1/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 2,000 | $92K | 6/1/2026 | View on chart |
| ALKT | ▲ Buy | Grant | 11,357 | $0 | 5/19/2026 | View on chart |
| SYM | ▼ Sell | Other | 2,000 | — | 5/1/2026 | View on chart |
| SYM | ▼ Sell | Other | 2,000 | — | 5/1/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 300 | $17K | 5/1/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 1,252 | $73K | 5/1/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 448 | $27K | 5/1/2026 | View on chart |
| SYM | ▼ Sell | Other | 2,000 | — | 4/1/2026 | View on chart |
| SYM | ▼ Sell | Other | 2,000 | — | 4/1/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 2,000 | $107K | 4/1/2026 | View on chart |
| SYM | ▼ Sell | Other | 4,000 | — | 3/9/2026 | View on chart |
| SYM | ▼ Sell | Other | 4,000 | — | 3/9/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 800 | $37K | 3/9/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 1,436 | $68K | 3/9/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 1,190 | $57K | 3/9/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 574 | $29K | 3/9/2026 | View on chart |
| SYM | ▲ Buy | Option Exercise | 10,345 | — | 3/5/2026 | View on chart |
| SYM | ▼ Sell | Gift | 5,000 | $0 | 12/11/2025 | View on chart |
| SYM | ▼ Sell | Other | 25,000 | — | 8/19/2025 | View on chart |
| SYM | ▼ Sell | Other | 25,000 | — | 8/19/2025 | View on chart |
| SYM | ▼ Sell | Open Market | 12,100 | $566K | 8/19/2025 | View on chart |
| SYM | ▼ Sell | Open Market | 6,900 | $331K | 8/19/2025 | View on chart |
| SYM | ▼ Sell | Open Market | 5,100 | $249K | 8/19/2025 | View on chart |
| SYM | ▼ Sell | Open Market | 900 | $45K | 8/19/2025 | View on chart |
| SYM | ▼ Sell | Gift | 5,000 | $0 | 6/12/2025 | View on chart |
| ALKT | ▲ Buy | Grant | 7,225 | $0 | 5/14/2025 | View on chart |
| SYM | ▲ Buy | Option Exercise | 4,060 | — | 3/1/2025 | View on chart |
| ALKT | ▲ Buy | Grant | 6,853 | $0 | 5/15/2024 | View on chart |
| SYM | ▲ Buy | Option Exercise | 10,447 | — | 3/1/2024 | View on chart |
| SYM | ▼ Sell | Gift | 5,000 | $0 | 12/13/2023 | View on chart |
| SYM | ▼ Sell | Open Market | 25,000 | $1.3M | 11/29/2023 | View on chart |
| SYM | ▼ Sell | Other | 25,000 | — | 11/29/2023 | View on chart |
| SYM | ▼ Sell | Other | 25,000 | — | 11/29/2023 | View on chart |
| SYM | ▼ Sell | Other | 68,656 | — | 8/30/2023 | View on chart |
| SYM | ▼ Sell | Open Market | 8,073 | $307K | 8/30/2023 | View on chart |
| SYM | ▼ Sell | Open Market | 10,257 | $404K | 8/30/2023 | View on chart |
| SYM | ▼ Sell | Open Market | 4,652 | $186K | 8/30/2023 | View on chart |
| SYM | ▼ Sell | Other | 68,656 | — | 8/30/2023 | View on chart |
| SYM | ▼ Sell | Open Market | 43,463 | $1.7M | 8/29/2023 | View on chart |
| SYM | ▼ Sell | Open Market | 2,211 | $89K | 8/29/2023 | View on chart |
| SYM | ▼ Sell | Other | 31,344 | — | 8/8/2023 | View on chart |
| SYM | ▼ Sell | Other | 31,344 | — | 8/8/2023 | View on chart |
| SYM | ▼ Sell | Open Market | 30,044 | $1.5M | 8/8/2023 | View on chart |
| SYM | ▼ Sell | Open Market | 1,300 | $67K | 8/8/2023 | View on chart |
| ALKT | ▲ Buy | Grant | 13,699 | $0 | 5/17/2023 | View on chart |
| SYM | ▲ Buy | Grant | 9,655 | — | 8/2/2022 | View on chart |
| SYM | ▲ Buy | Grant | 19,310 | — | 7/19/2022 | View on chart |
| SYM | ▲ Buy | Grant | 65,000 | $650K | 6/7/2022 | View on chart |
| SYM | ▲ Buy | Grant | 735,388 | — | 6/7/2022 | View on chart |
| ALKT | ▲ Buy | Grant | 14,179 | $0 | 5/18/2022 | View on chart |
| ALKT | ▲ Buy | Grant | 557 | $0 | 1/5/2022 | View on chart |
| ALKT | ▲ Buy | Grant | 461 | $0 | 10/5/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
SYM Announces Acquisition of Cellumation, Expanding Sortation Tech
Symbotic disclosed that it has acquired German automation firm Cellumation, adding next‑generation sortation technology to its portfolio. The deal was announced alongside a report that the company carries a $22.5 billion backlog, highlighting strong demand for its robotics solutions. A trading halt was placed earlier in the day as the news was released, after which quotations resumed. Analysts note the high valuation metrics as the stock continues to trade near the lower end of its 52‑week range.
SYM Announces Acquisition of Cellumation, Expanding Sortation Tech. Symbotic disclosed that it has acquired German automation firm Cellumation, adding next‑generation sortation technology to its portfolio. The deal was announced alongside a report that the company carries a $22.5 billion backlog, highlighting strong demand for its robotics solutions. A trading halt was placed earlier in the day as the news was released, after which quotations resumed. Analysts note the high valuation metrics as the stock continues to trade near the lower end of its 52‑week range.